SCHEMBL7441471

SCHEMBL7441471

CCOC(=O)CC1C(=O)N(CCc2ccccc2)Cc2cc(NCC(=O)c3ccc(C=NNC(=O)OCc4ccccc4)cc3)ccc2N1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 3/20 0.40
ALDH1A1 P00352 3/20 0.35
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ITGB3 P05106 7/20 0.34
ITGA2B P08514 7/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 1/20 0.34
ITGAV P06756 1/20 0.34
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
CTSL P07711 1/20 0.32
CTSB P07858 1/20 0.32
GRK2 P25098 1/20 0.32
GRK5 P34947 1/20 0.32
GRK3 P35626 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7441463 0.81 MIF (0.40) MIFALDH1A1NPC1HTTRAB9A
SCHEMBL7402544 0.79 ITGB3 (0.46) ALDH1A1SMN1; SMN2ITGB3ITGA2BITGAV
SCHEMBL7439572 0.79 HRH4 (0.39) ALDH1A1ITGB3ITGA2BITGAV
SCHEMBL7442820 0.76 ITGB3 (0.54) ITGB3ITGA2BITGAV
SCHEMBL7442838 0.76 ITGB3 (0.54) ITGB3ITGA2BITGAV
SCHEMBL7441446 0.74 ITGB3 (0.46) ITGB3ITGA2BITGAVCTSLCTSB
SCHEMBL7398371 0.74 ITGB3 (0.48) ITGB3ITGA2BITGAVCTSLCTSB
SCHEMBL7402539 0.73 ITGB3 (0.59) ITGB3ITGA2BITGAV
SCHEMBL7398374 0.73 ITGB3 (0.46) ALDH1A1SMN1; SMN2ITGB3ITGA2BITGAV
SCHEMBL7397826 0.72 GLA (0.38) ITGB3ITGA2BITGAVKMT2ACTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0674623-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1995-10-04 EP disclosed
WO-1994014776-A2 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-07-07 WO disclosed